Original-Research: HAEMATO AG - von GBC AGEinstufung von GBC AG zu HAEMATO AGUnternehmen: HAEMATO AGISIN: DE000A289VV1Anlass der Studie: Research study (Anno)Empfehlung: BUYKursziel: 30.75 EURKursziel auf Sicht von: 31.12.2024Letzte Ratingänderung: Analyst: Cosmin Filker; Marcel Goldmann- Compulsory manufacturer dis.
Original-Research: Advanced Blockchain AG (von GBC AG): Buy
boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.
Original-Research: Cenit AG (von GBC AG): BUY
boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.
newratings de
newratings.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newratings.de Daily Mail and Mail on Sunday newspapers.
newratings de
newratings.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newratings.de Daily Mail and Mail on Sunday newspapers.